Lunchtime Live

HSE approves offer on Skyclarys drug for Friedreich's Ataxia patients

13 min · I går
Billede af episoden HSE approves offer on Skyclarys drug for Friedreich's Ataxia patients

Description

The HSE today has approved a new offer from drug firm Biogen over ‘Skyclarys’, which will now be available with reimbursement to Friedreich’s Ataxia patients. This comes after mounting pressure, and months of campaigning… Joining Clare McKenna to discuss this is Teresa Kane, a mother of two children with Friedreich’s Ataxia and Niamh Ní Hoireabhaird, who lives with Friedrich’s Ataxia…

Comments

0

Be the first to comment

Sign up now and become a member of the Lunchtime Live community!

Start for free

Start 14 days free trial

99 kr. / month after trial. · Cancel anytime

  • Podcasts kun på Podimo
  • 20 lydbogstimer pr. måned
  • Gratis podcasts

All episodes

298 episodes